To provide a stable and consistent return through direct and indirect investment mainly in United Kingdom securities.
Name | % Net Assets |
---|---|
AstraZeneca | 7.5% |
KSK Power Ventur | 5.4% |
Indus Gas | 5.3% |
BP | 4.9% |
Resolution | 4.9% |
Essar Energy | 4.9% |
Reed Elsevier | 4.7% |
DS Smith | 4.2% |
iEnergizer Ltd | 3.7% |
Berkeley Group | 3.6% |
Key | % Net Assets |
---|---|
AstraZeneca | 7.5% |
KSK Power Ventur | 5.4% |
Indus Gas | 5.3% |
BP | 4.9% |
Other | 76.9% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/06/1964 |
---|---|
Fund Manager | Peter Cockburn |
TER | 1.62 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research